UNSPSC 85691807: Revision of autologous tissue substitute in right scapula, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right scapula, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PW5X7Z

UNSPSC 85691807 Revision of autologous tissue substitute in right scapula, external approach (Commodity) shows minimal alignment with recent state and local procurement activity. The code nominally describes a surgical procedure involving autologous tissue grafting, yet the recent opportunities tagged under it span occupational medical surveillance, independent disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out benefits, and emergency medical services for detained youth. None of these solicitations involve autologous tissue procedures or orthopedic graft revision work. The mismatch suggests either systematic miscoding by issuing bodies or classification drift in how state and local procurement systems apply this code to health services contracts more broadly.

The recent opportunities cluster across Arizona, California, Florida, and Washington, sourced from municipal retirement offices, county health systems, state transportation departments, and county juvenile justice agencies. Representative solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026, $750,000 over five years), the City of Long Beach's RFP for surgical procedure carve-out benefits (due October 7, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance (due October 9, 2026), and the County of Santa Clara Health System's solicitation for temporary health professional staffing (due October 7, 2026). The code shows no relevant recent activity for contractors offering autologous tissue revision services or orthopedic surgical procedures; firms pursuing this code should verify issuing-body intent before bid preparation, as the code's current use appears to encompass general health services procurement rather than the specific surgical procedure its name describes.